Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®

ST. LOUIS, March 04, 2025 (GLOBE NEWSWIRE) -- Optime Care, a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded partnership with Eton Pharmaceuticals (“Eton”), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. As part of this expanded collaboration, Optime Care will serve as the specialty pharmacy provider of a third product for Eton, dispensing the newly acquired GALZIN® (zinc acetate), an FDA-approved product used in the treatment of the ultra-rare metabolic condition of Wilson Disease.

To read more, click here